Portolan Capital Management, LLC Pure Tech Health PLC Transaction History
Portolan Capital Management, LLC
- $1.22 Billion
- Q1 2025
A detailed history of Portolan Capital Management, LLC transactions in Pure Tech Health PLC stock. As of the latest transaction made, Portolan Capital Management, LLC holds 11,885 shares of PRTC stock, worth $206,204. This represents 0.02% of its overall portfolio holdings.
Number of Shares
11,885Holding current value
$206,204% of portfolio
0.02%Shares
4 transactions
Others Institutions Holding PRTC
# of Institutions
7Shares Held
392KCall Options Held
0Put Options Held
0-
Birch Hill Investment Advisors LLC302KShares$5.24 Million0.3% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny44.9KShares$779,2050.0% of portfolio
-
Pentwater Capital Management LP Naples, FL33.6KShares$582,2660.01% of portfolio
-
Morgan Stanley New York, NY100Shares$1,7350.0% of portfolio
-
Ubs Group Ag20Shares$3470.0% of portfolio
About PureTech Health plc
- Ticker PRTC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,888,500
- Market Cap $484M
- Description
- PureTech Health plc, a clinical-stage biotherapeutics company, discovers, develops, and commercializes medicines for inflammatory, fibrotic and immunological, intractable cancers, lymphatic and gastrointestinal, neurological and neuropsychological, and other diseases in the United States. The company offers KarXT targeting muscarinic acetylcholi...